Search UK public tenders and contract notices
Official notices, one row per procedure. Filters use published facts only: delivery region from the notice, buyer type from the official classification, route and agreement type as published, never a Tenderline score.
Retenders uses the same keywords and compatible filters. Notice-only filters and CPV detail beyond the division do not carry over.
All records
Showing 241–255 · every procedure in the catalogue, any stage.
- AwardedOpen procedureFrameworkSME suitable
NHS National Framework Agreement for Omalizumab
NHS England · Central government · North East England, North West England, East Midlands, West Midlands, East of England, South East England
Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discreti…
Awarded to Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Limited, NOVARTIS PHARMACEUTICALS UK LIMITED
- Value
- £86mceiling, not a contract size
- Term
- 19 monthsup to 3.5 years with extensions
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #058e04
- AwardedOpen procedureFrameworkSME suitable
NHS National Framework for the supply of Tocilizumab Injection
NHS England · Central government · North East England, North West England, East Midlands, West Midlands, East of England, South East England
Project title: NHS National Framework for the supply of Tocilizumab Injection - 01 March 2026 Offer reference number: CM/TNS/25/5723 Period of framework: 1 March 2026 to 31 August 2027 with an option or options to extend (at the Authority’s…
Awarded to Celltrion Healthcare United Kingdom Limited, Fresenius Kabi Limited, Roche Products Ltd
- Value
- £188mceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #059160
- Planned · expected · not yet publishedSME suitable
Commercial Partner for Aseptic Services
Worcestershire Acute Hospitals NHS Trust · Central government · Nationwide (UK), West Midlands
The Founding NHS Trusts seek a commercial partner to establish an innovative company to design, build, commission, and operate a purpose-built MHRA-licensed aseptic manufacturing facility serving the West Midlands region. The Founding NHS T…
- Value
- £242m
- Term
- 10 yearsup to 15 years with extensions
- Submit via
- portal not identified
- Published
- #05f9fa
- CancelledOpen procedureFramework4 lots
NP38625 Compounded Aseptic Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Compounded Aseptic Medicines to NHS Scotland.
- Value
- £22mceiling, not a contract size
- Term
- 3 years
- Submit via
- Public Contracts Scotlandlogin required
- Published
- #0568b2
- Awarded · Open procedureFramework2 lotsSME suitable
NHS National Framework for Generics Housekeeping
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
NHS National Framework for Generics Housekeeping Offer reference number: CM/PHG/25/5733 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up…
Awarded to ACCORD-UK LTD, Alissa Healthcare Research Limited, Amarox Pharma +39 more · 2 awards
- Value
- £52mceiling, not a contract size
- Term
- 20 monthsup to 4 years with extensions
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #058823
- AwardedOpen procedureFrameworkSME suitable
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s di…
Awarded to AVENTIS PHARMA LIMITED t-a Sanofi, Mylan, NORTHUMBRIA PHARMA LTD +4 more
- Value
- £176mceiling, not a contract size
- Term
- 2 yearsup to 4 years with extensions
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #05838e
- AwardedBelow threshold - without competition
Clean Room Floor Mats
Northumbria Healthcare Facilities Management · Central government · delivery region not published
Clean Room Floor Mats to be fitted in Pharmacy first change area and second change area
Awarded to Dycem Ltd
- Value
- Not published
- Term
- Not published
- Submit via
- portal not identified
- Published
- #05f6bc
- AwardedOpen procedureSME · VCSE suitable
Provision of Nasal Naloxone
Ministry of Justice · Central government · Nationwide (UK)
The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for…
Awarded to Orion Medical Supplies Ltd
- Value
- £3.0m
- Term
- 5 years
- Submit via
- Jaggaerlogin required
- Published
- #0526b5
- AwardedCompetitive procedure with negotiation
Batch manufacture of high titer/titre GMP (U.S.A.) compliant lentiviral vector for FDA approval
University Of Edinburgh · Education · Scotland
We are planning a phase I/II clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy will use autologous CD34+ haematopoietic stem progenitor cells (HSPCs) which are modified ex vivo with LVV…
Awarded to Indiana University
- Value
- £900k
- Term
- 3 years
- Submit via
- Public Contracts Scotlandlogin required
- Published
- #0568ca
- Awarded · Direct award
ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial
Belfast Health & Social Care Trust · Central government · Northern Ireland
This procurement if for active and placebo capsule manufacture for the LAMDARCT Clinical Trial .
Awarded to ALMAC CLINICAL SERVICES LIMITED
- Value
- Not published
- Term
- Not published
- Submit via
- portal not identified
- Published
- #058571
- Awarded · Direct award
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
Western Health & Social Care Trust · Central government · Northern Ireland
Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
Awarded to NOVARTIS PHARMACEUTICALS UK LIMITED
- Value
- Not published
- Term
- Not published
- Submit via
- portal not identified
- Published
- #05ddfe
- Awarded · Open procedureFramework2 lotsSME suitable
NHS National Framework for Denosumab Injection commencing 1st January 2026
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s…
Awarded to ACCORD-UK LTD, Amgen Ltd, Biosimilar Collaborations Ireland Limited +5 more · 2 awards
- Value
- £57mceiling, not a contract size
- Term
- 12 monthsup to 3 years with extensions
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #05506a
- Award pending · decided Direct award
ANAKINRA 100MG/0.67ML INJECTION, AVATROMBOPAG 20MG TABLETS
Western Health & Social Care Trust · Central government · Northern Ireland
Supply of ANAKINRA 100MG/0.67ML INJECTION, AVATROMBOPAG 20MG TABLETS to meet clinical need in the Western Trust until 30/11/2028.
Intended award to Alloga UK
- Value
- Not published
- Term
- Not published
- Submit via
- portal not identified
- Published
- #05ee1f
- Awarded · Open procedure3 lotsSME suitable
Positive Pressure Ducted Gassing & Non Gassing Pharmaceutical Isolators
Wirral University Teaching Hospital NHS Foundation Trust · Central government · North West England
Provision of Positive Pressure Ducted Gassing & Non Gassing Pharmaceutical Isolators
Awarded to supplier not published
- Value
- £1.0m
- Term
- 5 years
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #056242
- AwardedAward procedure without prior publication of a call for competitionFramework
Leuprorelin (Prostap®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Leuprorelin (Prostap®) to NHS Scotland.
Awarded to Takeda UK Limited · 2 awards
- Value
- Not published
- Term
- Not published
- Submit via
- portal not identified
- Published
- #05dae3